Axonics, Inc. (AXNX)
USD 70.98
(N/A%)
USD 70.98
(N/A%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -6.08 Million USD | 89.8% |
| 2022 | -59.69 Million USD | 25.44% |
| 2021 | -80.06 Million USD | -45.8% |
| 2020 | -54.91 Million USD | 31.3% |
| 2019 | -79.93 Million USD | -146.08% |
| 2018 | -32.48 Million USD | -79.85% |
| 2017 | -18.06 Million USD | -3.79% |
| 2016 | -17.4 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -19.11 Million USD | -390.72% |
| 2024 Q2 | 6.89 Million USD | 136.1% |
| 2023 Q1 | -9.24 Million USD | -1490.68% |
| 2023 Q3 | 3.92 Million USD | 153.5% |
| 2023 Q2 | -7.34 Million USD | 20.61% |
| 2023 FY | -6.08 Million USD | 89.8% |
| 2023 Q4 | 6.57 Million USD | 67.36% |
| 2022 Q3 | -16.25 Million USD | 24.21% |
| 2022 Q4 | 665 Thousand USD | 104.09% |
| 2022 Q2 | -21.44 Million USD | 5.4% |
| 2022 Q1 | -22.66 Million USD | -49.47% |
| 2022 FY | -59.69 Million USD | 25.44% |
| 2021 Q1 | -22.5 Million USD | -98.3% |
| 2021 Q2 | -25.14 Million USD | -11.75% |
| 2021 Q3 | -17.25 Million USD | 31.41% |
| 2021 Q4 | -15.16 Million USD | 12.08% |
| 2021 FY | -80.06 Million USD | -45.8% |
| 2020 Q3 | -9.16 Million USD | 53.66% |
| 2020 Q2 | -19.78 Million USD | -35.35% |
| 2020 Q1 | -14.61 Million USD | 35.76% |
| 2020 Q4 | -11.34 Million USD | -23.78% |
| 2020 FY | -54.91 Million USD | 31.3% |
| 2019 Q3 | -25 Million USD | -31.19% |
| 2019 Q1 | -13.11 Million USD | -35.72% |
| 2019 FY | -79.93 Million USD | -146.08% |
| 2019 Q4 | -22.75 Million USD | 9.02% |
| 2019 Q2 | -19.06 Million USD | -45.32% |
| 2018 Q2 | -8.64 Million USD | -30.95% |
| 2018 FY | -32.48 Million USD | -79.85% |
| 2018 Q4 | -9.66 Million USD | -27.74% |
| 2018 Q3 | -7.56 Million USD | 12.51% |
| 2018 Q1 | -6.6 Million USD | -33.9% |
| 2017 Q1 | -4.3 Million USD | 0.0% |
| 2017 Q2 | -4.3 Million USD | 0.0% |
| 2017 Q3 | -4.52 Million USD | -5.08% |
| 2017 Q4 | -4.93 Million USD | -9.06% |
| 2017 FY | -18.06 Million USD | -3.79% |
| 2016 FY | -17.4 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 90.12% |
| BrainsWay Ltd. | -4.19 Million USD | -45.056% |
| Cerus Corporation | -37.48 Million USD | 83.761% |
| Envoy Medical, Inc. | -29.9 Million USD | 79.644% |
| electroCore, Inc. | -18.83 Million USD | 67.675% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 31.209% |
| IceCure Medical Ltd | -14.65 Million USD | 58.449% |
| Inogen, Inc. | -102.44 Million USD | 94.058% |
| OrthoPediatrics Corp. | -20.97 Million USD | 70.974% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 88.44% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 55.708% |
| MaxCyte, Inc. | -37.92 Million USD | 83.946% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 48.666% |
| Nexalin Technology, Inc. | -4.64 Million USD | -30.961% |
| Orthofix Medical Inc. | -151.39 Million USD | 95.979% |
| PAVmed Inc | -64.17 Million USD | 90.513% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 88.397% |
| RxSight, Inc. | -48.6 Million USD | 87.475% |
| Sight Sciences, Inc. | -55.54 Million USD | 89.04% |
| SI-BONE, Inc. | -43.33 Million USD | 85.952% |
| TELA Bio, Inc. | -46.66 Million USD | 86.954% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 87.708% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 55.179% |
| Acutus Medical, Inc. | -81.66 Million USD | 92.545% |
| Talis Biomedical Corporation | -62 Million USD | 90.182% |
| Spectral AI, Inc. | -20.85 Million USD | 70.807% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 89.983% |
| CVRx, Inc. | -41.19 Million USD | 85.223% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 1050.959% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 44.429% |
| Bioventus Inc. | -156.23 Million USD | 96.103% |
| Venus Concept Inc. | -37.25 Million USD | 83.656% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 89.688% |
| LivaNova PLC | 17.54 Million USD | 134.697% |
| 908 Devices Inc. | -36.39 Million USD | 83.274% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 96.738% |
| Nemaura Medical Inc. | -14.14 Million USD | 56.956% |
| NeuroPace, Inc. | -32.95 Million USD | 81.527% |
| LENSAR, Inc. | -14.38 Million USD | 57.672% |
| Apyx Medical Corporation | -18.71 Million USD | 67.466% |
| Cutera, Inc. | -162.83 Million USD | 96.261% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 43.786% |
| BioSig Technologies, Inc. | -29.04 Million USD | 79.037% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 92.636% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 72.439% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 108.987% |
| Outset Medical, Inc. | -172.79 Million USD | 96.477% |
| IRIDEX Corporation | -9.57 Million USD | 36.385% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 94.251% |
| IRadimed Corporation | 17.19 Million USD | 135.41% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 26.152% |
| INVO Bioscience, Inc. | -8.03 Million USD | 24.228% |
| Telesis Bio, Inc. | -47.72 Million USD | 87.243% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 159.436% |
| Varex Imaging Corporation | -47.7 Million USD | 87.237% |
| Quipt Home Medical Corp. | -2.78 Million USD | -118.678% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 46.057% |
| Pulmonx Corporation | -60.84 Million USD | 89.994% |
| Dynatronics Corporation | -2.69 Million USD | -125.672% |
| Modular Medical, Inc. | -17.47 Million USD | 65.152% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 46.536% |
| Semler Scientific, Inc. | 20.58 Million USD | 129.578% |
| InMode Ltd. | 197.91 Million USD | 103.076% |
| Bruker Corporation | 427.2 Million USD | 101.425% |
| Cytosorbents Corporation | -28.5 Million USD | 78.644% |
| DexCom, Inc. | 541.5 Million USD | 101.124% |
| Align Technology, Inc. | 445.05 Million USD | 101.368% |
| Viveve Medical, Inc. | -22.02 Million USD | 72.361% |
| ZimVie Inc. | -393.28 Million USD | 98.452% |
| Movano Inc. | -29.28 Million USD | 79.21% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 49.885% |
| Nexalin Technology, Inc. | -4.64 Million USD | -30.961% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 1050.959% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 97.265% |
| Profound Medical Corp. | -28.56 Million USD | 78.69% |
| Insulet Corporation | 206.3 Million USD | 102.951% |
| enVVeno Medical Corporation | -23.51 Million USD | 74.111% |
| Surmodics, Inc. | -11.54 Million USD | 47.254% |
| iCAD, Inc. | -4.84 Million USD | -25.603% |
| Nuwellis, Inc. | -20.2 Million USD | 69.875% |
| Biotricity, Inc. | -14.09 Million USD | 56.805% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 95.067% |
| Aethlon Medical, Inc. | -12.2 Million USD | 50.132% |
| InspireMD, Inc. | -19.91 Million USD | 69.432% |
| PAVmed Inc. | -64.17 Million USD | 90.513% |
| BIOLASE, Inc. | -20.63 Million USD | 70.492% |
| Beyond Air, Inc. | -60.24 Million USD | 89.894% |
| FONAR Corporation | 10.56 Million USD | 157.611% |
| AxoGen, Inc. | -21.71 Million USD | 71.965% |
| Vivani Medical, Inc. | -25.65 Million USD | 76.267% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 121.35% |
| Inari Medical, Inc. | -1.63 Million USD | -272.127% |
| UFP Technologies, Inc. | 44.92 Million USD | 113.552% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -18.621% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 7.83% |
| Tenon Medical, Inc. | -15.58 Million USD | 60.927% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 60.534% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 82.77% |
| AdaptHealth Corp. | -678.89 Million USD | 99.103% |
| Sintx Technologies, Inc. | -8.25 Million USD | 26.286% |
| NanoVibronix, Inc. | -3.71 Million USD | -64.053% |
| Quanterix Corporation | -32.33 Million USD | 81.172% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 46.057% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 1355.258% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 98.015% |
| TransMedics Group, Inc. | -25.02 Million USD | 75.675% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 72.494% |
| NeuroMetrix, Inc. | -6.52 Million USD | 6.761% |
| Hyperfine, Inc. | -44.23 Million USD | 86.238% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 92.245% |
| Biomerica, Inc. | -5.97 Million USD | -1.84% |
| Bone Biologics Corporation | -8.94 Million USD | 31.968% |
| AVITA Medical, Inc. | -39.16 Million USD | 84.457% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 38.838% |
| Silk Road Medical, Inc | -55.74 Million USD | 89.078% |